Hydralazine injection labels and packages: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Hydralazine}} | {{Hydralazine}} | ||
{{CMG}}; {{AE}} {{AK}} | {{CMG}}; {{AE}} {{AK}} | ||
==Labels and Packages== | |||
PACKAGE LABEL - PRINCIPAL DISPLAY - Hydralazine Hydrochloride 1 mL Single Dose Vial Label | PACKAGE LABEL - PRINCIPAL DISPLAY - Hydralazine Hydrochloride 1 mL Single Dose Vial Label | ||
Revision as of 20:33, 12 March 2014
| Hydralazine |
|---|
| HYDRALAZINE tablet® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings |
| Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| How Supplied/Storage and Handling |
| Labels and Packages |
| HYDRALAZINE injection® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings |
| Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| How Supplied/Storage and Handling |
| Labels and Packages |
| Clinical Trials on Hydralazine |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
Labels and Packages
PACKAGE LABEL - PRINCIPAL DISPLAY - Hydralazine Hydrochloride 1 mL Single Dose Vial Label
NDC 63323-614-55
NP601401
hydrALAZINE HYDROCHLORIDE INJECTION, USP 20 mg/mL
FOR IM OR IV USE
1 mL Rx only
Single Dose Vial WARNING: DISCARD UNUSED PORTION.
 |
PACKAGE LABEL - PRINCIPAL DISPLAY - Hydralazine Hydrochloride 1 mL Single Dose Vial Tray Label NDC 63323-614-55
NP601401
hydrALAZINE HYDROCHLORIDE INJECTION, USP
FOR INTRAMUSCULAR OR INTRAVENOUS USE
20 mg/mL
1 mL Single Dose Vial
N+ and NOVAPLUS are registered trademarks of Novation, LLC
Rx only
 |
References
- ↑ "HYDRALAZINE HYDROCHLORIDE INJECTION [FRESENIUS KABI USA, LLC]". Retrieved 10 March 2014.